United Therapeutics Corp (FRA:UTH)
€ 245.3 4.6 (1.91%) Market Cap: 10.88 Bil Enterprise Value: 8.92 Bil PE Ratio: 12.50 PB Ratio: 2.19 GF Score: 89/100

United Therapeutics Corp at Jefferies Virtual London Healthcare Conference Transcript

Nov 17, 2020 / 06:45PM GMT
Release Date Price: €120
Eun Kyung Yang
Jefferies LLC, Research Division - MD & Senior Equity Research Analyst

Good morning and good afternoon. This is Eun Kyung Yang a biotech analyst with Jeffries. So next to presenting companies, United therapeutics, it's one of your fireside chat. And presenting from UTHR is James Edgemond, CFO. James, thanks for joining us. But before we start, Dewey is going to give us a disclaimer. Dewey?

Dewey Steadman
United Therapeutics Corporation - Head of IR

Yes. Good afternoon. Our remarks today may include forward-looking information about our business, and please see our SEC filings for risks and uncertainties that could cause actual results to differ. And thank you. And so I'll turn it back over to you, Eun.

Eun Kyung Yang
Jefferies LLC, Research Division - MD & Senior Equity Research Analyst

So James, why don't we start with a quick overview from you, then we can go in Q&As?

James C. Edgemond
United Therapeutics Corporation - CFO & Treasurer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot